Alan Skarbnik, MD | Authors


Challenges With Triplet Regimens for the Treatment of Hematologic Malignancies

April 18, 2018

Alan Skarbnik, MD, director of the Chronic Lymphocytic Leukemia Program at John Theurer Cancer Center, discusses the possibility of triplet combinations for the treatment of hematologic malignances. The biggest challenge with this type of treatment regimen is the increased risk of adverse events.